Galmed Pharmaceuticals Ltd (GLMD) — Working Capital to Net Assets Ratio
Galmed Pharmaceuticals Ltd (GLMD) has a Working Capital to Net Assets ratio of 100.0% as of December 2025. Working capital of $15.78 Million (current assets of $18.63 Million minus current liabilities of $2.85 Million) is measured against net assets of $15.78 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Galmed Pharmaceuticals Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Galmed Pharmaceuticals Ltd Working Capital to Net Assets (2012–2025)
This chart shows how Galmed Pharmaceuticals Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting working capital of $15.78 Million against net assets of $15.78 Million USD. Check GLMD tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Galmed Pharmaceuticals Ltd (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Galmed Pharmaceuticals Ltd from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Galmed Pharmaceuticals Ltd stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.0% | $15.78 Million | $15.78 Million | $18.63 Million | $2.85 Million | ▲ +14.6 pp |
| 2024 | 85.4% | $13.95 Million | $16.33 Million | $16.12 Million | $2.17 Million | ▲ +9.9 pp |
| 2023 | 75.6% | $10.49 Million | $13.88 Million | $13.24 Million | $2.75 Million | ▼ -11.1 pp |
| 2022 | 86.6% | $11.63 Million | $13.42 Million | $14.72 Million | $3.09 Million | ▼ -12.3 pp |
| 2021 | 98.9% | $30.18 Million | $30.50 Million | $36.05 Million | $5.88 Million | ▼ -0.3 pp |
| 2020 | 99.2% | $43.80 Million | $44.15 Million | $51.81 Million | $8.01 Million | ▼ -0.3 pp |
| 2019 | 99.5% | $69.50 Million | $69.85 Million | $76.43 Million | $6.93 Million | ▼ -0.3 pp |
| 2018 | 99.8% | $87.70 Million | $87.89 Million | $90.41 Million | $2.71 Million | ▲ +2.9 pp |
| 2017 | 96.9% | $15.30 Million | $15.79 Million | $19.15 Million | $3.85 Million | ▼ -3.8 pp |
| 2016 | 100.7% | $11.15 Million | $11.07 Million | $15.73 Million | $4.58 Million | ▲ +4.0 pp |
| 2015 | 96.7% | $20.84 Million | $21.55 Million | $23.38 Million | $2.54 Million | ▼ -2.1 pp |
| 2014 | 98.8% | $31.03 Million | $31.41 Million | $32.15 Million | $1.12 Million | ▲ +20.1 pp |
| 2013 | 78.7% | $-1.54 Million | $-1.95 Million | $153.00K | $1.69 Million | ▲ +89.8 pp |
| 2012 | -11.1% | $219.00K | $-1.98 Million | $732.00K | $513.00K | — |